Does cellular iron dysregulation play a causative role in Parkinson's disease?

被引:110
|
作者
Kaur, D [1 ]
Andersen, J [1 ]
机构
[1] Buck Inst Aging Res, Novato, CA 94945 USA
关键词
Parkinson's disease; oxidative stress; iron; iron regulatory proteins; mitochondrial dysfunction; alpha-synuclein;
D O I
10.1016/j.arr.2004.01.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Selective dopaminergic cell loss in Parkinson's disease is correlated with increased levels of cellular iron. It is still hotly debated as to whether the increase in iron is an upstream event which acts to promote neurodegeneration via formation of oxidative stress or whether iron accumulates as a by-product of the neuronal cell loss. Here we review evidence for loss of iron homeostasis as a causative factor in disease-associated neurodegeneration and the primary players which may be involved. A series of recent studies suggest that iron regulatory proteins (IRPs) coordinate both cellular iron levels and energy metabolism, both of which are disrupted in Parkinson's disease (PD) and may in turn contribute to increased levels of oxidative stress associated with the disease. Iron has also been recently been implicated in promotion of alpha-synuclein aggregation either directly or via increasing levels of oxidative stress suggesting an important role for it in Lewy body formation, another important hallmark of the disease. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:327 / 343
页数:17
相关论文
共 50 条
  • [31] Cellular and Molecular Mechanisms of Parkinson’s Disease: Neurotoxins, Causative Genes, and Inflammatory CytokinesCellular and Molecular Mechanisms of Parkinson’s DiseaseNagatsu and Sawada
    Toshi Nagatsu
    Makoto Sawada
    Cellular and Molecular Neurobiology, 2006, 26 (4) : 779 - 800
  • [32] Iron dysregulation in Huntington's disease
    Muller, Michelle
    Leavitt, Blair R.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 (03) : 328 - 350
  • [33] The Role of Cellular Defense Systems of Ferroptosis in Parkinson's Disease and Alzheimer's Disease
    Chu, Jie
    Li, Jingwen
    Sun, Lin
    Wei, Jianshe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [34] Dopaminergic dysregulation syndrome in Parkinson's disease
    Katzenschlager, Regina
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 271 - 275
  • [35] Dopamine dysregulation syndrome in Parkinson's disease
    Borg, M.
    Bayreuther, C.
    REVUE NEUROLOGIQUE, 2008, 164 (04) : 310 - 321
  • [36] Dopamine dysregulation syndrome in Parkinson's disease
    Evans, AH
    Lees, AJ
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (04) : 393 - 398
  • [37] Inflammation as a causative factor in the aetiology of Parkinson's disease
    Whitton, P. S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (08) : 963 - 976
  • [38] Crohn's disease and risk of fracture: does thyroid disease play a role?
    Nakechand Pooran
    Pankaj Singh
    Simmy Bank
    World Journal of Gastroenterology, 2003, 9 (03) : 615 - 618
  • [39] Crohn's disease and risk of fracture: Does thyroid disease play a role?
    Pooran, N
    Singh, P
    Ganem, A
    Davidoff, S
    Bank, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S248 - S249
  • [40] Crohn's disease and risk of fracture: does thyroid disease play a role?
    Pooran, N
    Singh, P
    Bank, S
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (03) : 615 - 618